132 related articles for article (PubMed ID: 6408180)
41. Purified human macrophage secretions suppress tumor growth in the mouse.
Cameron DJ
J Reticuloendothel Soc; 1983 Jul; 34(1):45-52. PubMed ID: 6410064
[TBL] [Abstract][Full Text] [Related]
42. In vitro induction of intracellular killing of parasitic protozoa by macrophages.
Mauel J
Immunobiology; 1982 Apr; 161(3-4):392-400. PubMed ID: 6807834
[TBL] [Abstract][Full Text] [Related]
43. The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
Somers SD; Mastin JP; Adams DO
J Immunol; 1983 Oct; 131(4):2086-93. PubMed ID: 6413586
[TBL] [Abstract][Full Text] [Related]
44. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
45. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
James SL; Sher A; Lazdins JK; Meltzer MS
J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
[TBL] [Abstract][Full Text] [Related]
46. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.
Nacy CA; Meltzer MS; Leonard EJ; Wyler DJ
J Immunol; 1981 Dec; 127(6):2381-6. PubMed ID: 7299130
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
Adams DO; Johnson WJ; Marino PA
Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
[TBL] [Abstract][Full Text] [Related]
48. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages.
Flandin JF; Chano F; Descoteaux A
Eur J Immunol; 2006 Feb; 36(2):411-20. PubMed ID: 16369915
[TBL] [Abstract][Full Text] [Related]
49. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
50. Augmentation of an antitumor CTL response In vivo by inhibition of suppressor macrophage nitric oxide.
Medot-Pirenne M; Heilman MJ; Saxena M; McDermott PE; Mills CD
J Immunol; 1999 Dec; 163(11):5877-82. PubMed ID: 10570272
[TBL] [Abstract][Full Text] [Related]
51. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
52. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
53. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
Murray HW; Rubin BY; Rothermel CD
J Clin Invest; 1983 Oct; 72(4):1506-10. PubMed ID: 6415111
[TBL] [Abstract][Full Text] [Related]
54. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.
Ockenhouse CF; Schulman S; Shear HL
J Immunol; 1984 Sep; 133(3):1601-8. PubMed ID: 6431003
[TBL] [Abstract][Full Text] [Related]
55. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
56. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
57. Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
Denkers EY; Butcher BA
Trends Parasitol; 2005 Jan; 21(1):35-41. PubMed ID: 15639739
[TBL] [Abstract][Full Text] [Related]
58. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
James SL; Correa-Oliveira R; Leonard EJ
J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
[TBL] [Abstract][Full Text] [Related]
59. Nitrite production by activated murine macrophages correlates with their toxoplasmastatic activity, Ia antigen expression, and production of H2O2.
Nibbering PH; Langermans JA; van de Gevel JS; van der Hulst MB; van Furth R
Immunobiology; 1991 Dec; 184(1):93-105. PubMed ID: 1666060
[TBL] [Abstract][Full Text] [Related]
60. Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.
Pidgeon C; Schreiber RD; Schultz RM
J Immunol; 1983 Jul; 131(1):311-4. PubMed ID: 6408176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
